Bone mineral density is the amount of bone mineral in bones, which is measured by an X-ray.
Scope of the Report:
This report studies the Bone Mineral Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bone Mineral Testing market by product type and applications/end industries.
A bone mineral density test is performed when bones become weaker, which may result in osteoporosis or fractures. These tests are noninvasive, painless, and require no administration of medication.
The global Bone Mineral Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2018 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bone Mineral Testing.
Europe also play important roles in global market, with market size of xx million USD in 2018 and will be xx million USD in 2024, with a CAGR of xx%.
Market Segment by Companies, this report covers:
Roche
DiaSorin
BioMerieux
Abbott Laboratories
Quidel Corporation
Siemens
Alere
Beckman Coulter
Market Segment by Regions, regional analysis covers:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers:
Bone marker test
Immunoassay
Market Segment by Applications, can be divided into:
Hyperparathyroidism
Hypoparathyroidism
Osteoporosis
Paget\'s Disease
Others